Pulmonary Cell News Volume 13.29 | Dec 05 2024

    0
    93







    2024-12-05 | PULCN 13.29


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 13.29 – 5 December, 2024
    TOP STORY

    Impact of Fluid Balance on the Development of Lung Injury

    39 healthy female pigs, divided into four groups, were ventilated for 48 hours with high or low mechanical power; and high or low targeted fluid balance.
    [American Journal of Respiratory and Critical Care Medicine]

    Abstract
    Immunostained airway epithelial cells at the air-liquid interface with text describing a free on-demand course on pulmonary cell culture.
    PUBLICATIONSListed by the impact factor of the journal

    Dual Therapy with Corticosteroid Ablates the Beneficial Effect of DP2 Antagonism in Chronic Experimental Asthma

    Using a preclinical model of chronic experimental asthma, investigators demonstrated that rhinovirus-induced exacerbations increased prostaglandin D2 release, mucus production, transforming growth factor-β1 and type-2 inflammation.
    [Nature Communications]

    Full Article

    Ficolin-1 Ameliorates Pulmonary Fibrosis via Directly Binding to TGF-β1

    The expression of ficolin-1 in the plasma of idiopathic pulmonary fibrosis and connective tissue disease- interstitial lung disease patients was first determined.
    [Journal of Translational Medicine]

    Full Article

    Preclinical Studies on the Antitumor and Non-Toxic Effect of Combining Pirfenidone with Vinorelbine and Carboplatin in Non-Small Cell Lung Cancer

    Researchers performed preclinical studies on the combination of pirfenidone with vinorelbine, or with vinorelbine plus carboplatin, in NSCLC.
    [International Journal of Cancer]

    AbstractGraphical Abstract

    Co-Culture of Human AT2 Cells with Fibroblasts Reveals a MUC5B Phenotype: Insights from an Organoid Model

    The authors analyzed the interaction of primary fibroblasts and alveolar type 2 (AT2) pneumocytes in an organoid model. Single-cell analysis, histology, and qRT-PCR revealed that fibroblasts expressing high levels of fibrosis markers regulated IL-6/activator of transcription-3 signaling in AT2 cells.
    [Molecular Medicine]

    Full Article

    CCDC34 Maintains Stemness Phenotype through β-Catenin-Mediated Autophagy and Promotes EGFR-TKI Resistance in Lung Adenocarcinoma

    Scientists found that coiled-coil domain-containing 34 (CCDC34) may be associated with lung adenocarcinoma stemness through weighted gene co-expression network analysis.
    [Cancer Gene Therapy]

    Abstract

    ErbB Deletion Effect on Pulmonary Intracellular Surfactant Distribution

    Researchers hypothesized that ErbB4 deletion affected the ultrastructure of alveolar epithelial type II cells, specifically lamellar bodies and the intracellular distribution of the immunomodulating hydrophilic surfactant proteins (SP)-A and the hydrophobic SP-B.
    [Experimental Lung Research]

    Full Article
    Your culture ware impacts your ALI cultures - Learn more about using Transwell inserts
    REVIEWS

    The Role of PM2.5 Exposure in Lung Cancer: Mechanisms, Genetic Factors, and Clinical Implications

    The authors summarize the current understanding of how exposure to fine particulate matter (PM2.5 ) induces lung carcinogenesis and accelerates lung cancer development.
    [EMBO Molecular Medicine]

    Full Article

    Efficacy and Mechanism of Combining Radiotherapy and Immunotherapy in Stage IV Non-Small Cell Lung Cancer

    Scientists explore the efficacy and safety of combining radiotherapy with immunotherapy in the treatment of stage IV NSCLC, delving into the intricacies of their underlying mechanism.
    [Current Treatment Options in Oncology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

    Merus, N.V. announced that the US FDA approved BIZENGRI®, a treatment indicated for adults with pancreatic adenocarcinoma or NSCLC that are advanced unresectable or metastatic and harbor a neuregulin 1 (NRG1) gene fusion who have disease progression on or after prior systemic therapy.
    [Merus, N.V.]

    Press Release
    FEATURED EVENT

    Translating Targeted Therapies in Combination with Radiotherapy

    January 26-29, 2025
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    PhD Studentship – Development of Novel Drug Combinations

    University of Bradford – Bradford, England, United Kingdom

    Faculty Position – Translational Cancer Research

    Northwell Health – Manhasset, New York, United States

    Group Leaders – Heart and Lung Research

    Max Planck Institute – Bad Nauheim, Hessen

    Clinical Research Associate – Pulmonary Research Program

    Cedars Sinai – Los Angeles, California, United States

    Postdoctoral Scientist – Small Cell Lung Cancer

    Cancer Research UK – Manchester, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2